Global High-Throughput Screening Market to Surpass $21 Billion by 2023

January 17, 2019

WELLESLEY, Mass., Jan. 17, 2019 – Due to the increasing popularity of contract research organizations (CROs), technological breakthroughs, increasing government funding, R&D spending by firms and additional factors, the global market for high-throughput screening (HTS) is steadily advancing, according to BCC Research.

The global HTS market was valued at $14.4 billion in 2018 and is expected to reach $21.1 billion by 2023 at a compound annual growth rate (CAGR) of 7.9% during the forecast period, according to the report “High-Throughput Screening: Technologies and Global Markets.”

Key players in the market include: Albany Molecular Research Inc.,  Thermo Fisher Scientific, PerkinElmer Inc., Olympus Corporation (OCPNF), GE Healthcare, Danaher Corporation (DHR), Sysmex Corporation (SSMXF) and Becton Dickinson and Co. (BDX).

Research Highlights:

  • The U.S. is expected to be the largest contributor at the global market level and the biggest contributor in the North American region. This growth is attributed to rising innovations in HTS technology.
  • The increasing application of HTS in the production of new innovative drugs, cancer research and cellular study is a major factor driving HTS market growth.
  • Among all the detection methods in the market, mass spectrometry is expected to dominate the detection method segment.

“Several technologies are used for high-throughput screening, such as cell-based assays, lab-on-a-chip, ultra-high-throughput screening and label-free technology,” said Anuj Pathak, the report’s author. “Among these technologies, cell-based assays are expected to hold the largest share in the global high-throughput screening market due to its extensive use in cell culture, especially in 2D cell culture.”

Asia-Pacific as an Emerging HTS Market    

Asia-Pacific (APAC) holds a significant share of the global HTS market and is an emerging market for high-throughput screening. Factors driving this market growth include the increasing demand for highly efficient screening systems and rising drug discovery initiatives among pharmaceuticals and biotechnology companies in the region. China is expected to be a major contributor at the global level and the largest contributor in the region.

Editors/reporters requesting analyst interviews should contact Eric Surber at

High-Throughput Screening: Technologies and Global Markets( PHM205A )
Publish Date: Jan 2019    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.